Pharma IQ Members

Kristof
Van Emelen

Kristof Van Emelen
In recent years we have seen a slow but steady paradigm shift in how pharmaceutical companies approach early drug discovery. The role of discovery partnerships in a high-failure-rate industry such as bio/pharma is thus pivotal for enhancing innovation while de-risking in the pre-clinical stages. In this interview Kristof Van Emelen, Scientific...Full Article »